Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CSTL
#2453
Castle Biosciences, Inc. - Common stock
33.4
4
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.39%
Monthly Change
+39.74%
6 month change
+16.35%
Year Change
+35.85%
Previous Close
34.2
6
Open
33.2
1
Low
33.1
7
High
33.6
8
Volume
177
Markets
US Stock Market
Healthcare
Diagnostics & Research
CSTL
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
24.98 M
25.41 M
26.58 M
27.45 M
28.51 M
29.73 M
30.55 M
Valuation ratios
Enterprise value
1.27 B
759.72 M
482.44 M
503.96 M
650.32 M
1.05 B
994.74 M
Price to earnings ratio
-124.35
-34.57
-8.83
-10.26
42.98
-46.87
-53.54
Price to sales ratio
20.29
11.45
4.33
2.68
2.35
3.28
2.84
Price to cash flow ratio
128.85
-56.77
-14.25
104.62
12.02
17.52
23.35
Price to book ratio
3.06
2.62
1.49
1.5
1.71
2.39
0.54
Enterprise value to EBITDA ratio
-178.19
-20.71
-5.98
-9.03
27.01
-481.62
-20.13
Profitability ratios
Return on assets %
-0.02
-0.07
-0.15
-0.13
0.03
-0.04
-0
Return on equity %
-0.02
-0.08
-0.17
-0.15
0.04
-0.05
-0
Return on invested capital %
-215
-205.14
-216.68
-171.67
17.63
-65.06
-7
Gross margin %
84.54
83.18
76.64
79.53
81.99
79.38
77.25
Operating margin %
-10.44
-42.6
-53.16
-30.93
2.61
-12.44
-2.97
EBITDA margin %
-11.35
-38.99
-58.91
-25.38
7.26
-0.63
0.79
Net margin %
-16.42
-33.26
-48.99
-26.15
5.5
-7.02
-1.99
Liquidity ratios
Quick ratio
20.47
14.13
7.98
6.04
7.13
5.11
5.85
Current ratio
20.58
14.21
8.09
6.2
7.29
5.26
6.04
Inventory turnover
5.61
7.47
—
—
—
—
—
Asset turnover
0.22
0.21
0.3
0.49
0.67
0.59
0.19
Solvency ratios
Debt to assets ratio
0
—
—
—
0.02
0.02
0.02
Debt to equity ratio
0
—
—
—
0.02
0.02
0.02
Long term debt to total assets ratio
—
—
—
—
0.02
0.02
0.02
Long term debt to total equity ratio
—
—
—
—
0.02
0.02
0.02
Per share metrics
Operating cash flow per share
0.52
-0.76
-1.6
-0.21
2.22
2.22
1.47
EBIT per share
-0.45
-1.59
-3.5
-2.54
0.28
-1.48
-2.22
EBITDA per share
-0.38
-1.46
-3.1
-2.08
0.82
-0.08
-1.69
Total debt per share
0
—
—
—
0.35
0.33
0.33
Cash per share
21.65
13.11
9.93
9.07
15.95
16.64
15.51
Net current asset value per share
22.7
14.07
11.22
11.03
12.31
12.46
11.22
Tangible book value per share
21.96
16.38
10.47
10.22
11.95
12.81
12.33
Working capital per share
21.59
13.08
9.83
9.25
10.62
10.09
9.36
Book value per share
21.96
16.38
15.32
14.6
15.58
16.24
15.46
News
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know
Does Castle Biosciences (CSTL) Have the Potential to Rally 31.46% as Wall Street Analysts Expect?
Castle Biosciences, Inc. (CSTL) Q2 2026 Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus